Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Nakano

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|February 13, 2010
Nationwide survey of current medical practices for hospitalized elderly with spine fractures in JapanAtsushi Harada, Yukihiro Matsuyama, Tetsuo Nakano, et al.
Current Medical Research and Opinion|December 25, 2012
Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trialToshitsugu Sugimoto, Masataka Shiraki, Tetsuo Nakano, et al.
Journal of Bone and Mineral Metabolism|March 7, 2020
Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA)Toshio Matsumoto, Kazuhiko Yamamoto, Tsutomu Takeuchi, et al.
Journal of Bone and Mineral Metabolism|April 27, 2013
Justification criteria for vertebral fractures: year 2012 revisionSatoshi Mori, Satoshi Soen, Hiroshi Hagino, et al.
Journal of Bone and Mineral Metabolism|April 9, 2017
Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST studyHiroshi Hagino, Masako Ito, Junko Hashimoto, et al.
Advances in Therapy|June 21, 2017
24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture RiskToshitsugu Sugimoto, Masataka Shiraki, Masao Fukunaga, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture riskToshitaka Nakamura, Toshitsugu Sugimoto, Tetsuo Nakano, et al.
Current Medical Research and Opinion|July 11, 2018
A randomized, double-blind, placebo-controlled study of once weekly elcatonin in primary postmenopausal osteoporosisToshitsugu Sugimoto, Masataka Shiraki, Tetsuo Nakano, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|December 1, 2010
Nationwide one-decade survey of hip fractures in JapanHiroshi Hagino, Keizo Sakamoto, Atsushi Harada, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|October 3, 2006
Effects of unipedal standing balance exercise on the prevention of falls and hip fracture among clinically defined high-risk elderly individuals: a randomized controlled trialKeizo Sakamoto, Toshitaka Nakamura, Hiroshi Hagino, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|February 13, 2010
Nationwide survey of current medical practices for hospitalized elderly with spine fractures in JapanAtsushi Harada, Yukihiro Matsuyama, Tetsuo Nakano, et al.
Current Medical Research and Opinion|December 25, 2012
Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trialToshitsugu Sugimoto, Masataka Shiraki, Tetsuo Nakano, et al.
Journal of Bone and Mineral Metabolism|March 7, 2020
Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA)Toshio Matsumoto, Kazuhiko Yamamoto, Tsutomu Takeuchi, et al.
Journal of Bone and Mineral Metabolism|April 27, 2013
Justification criteria for vertebral fractures: year 2012 revisionSatoshi Mori, Satoshi Soen, Hiroshi Hagino, et al.
Journal of Bone and Mineral Metabolism|April 9, 2017
Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST studyHiroshi Hagino, Masako Ito, Junko Hashimoto, et al.
Advances in Therapy|June 21, 2017
24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture RiskToshitsugu Sugimoto, Masataka Shiraki, Masao Fukunaga, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture riskToshitaka Nakamura, Toshitsugu Sugimoto, Tetsuo Nakano, et al.
Current Medical Research and Opinion|July 11, 2018
A randomized, double-blind, placebo-controlled study of once weekly elcatonin in primary postmenopausal osteoporosisToshitsugu Sugimoto, Masataka Shiraki, Tetsuo Nakano, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|December 1, 2010
Nationwide one-decade survey of hip fractures in JapanHiroshi Hagino, Keizo Sakamoto, Atsushi Harada, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|October 3, 2006
Effects of unipedal standing balance exercise on the prevention of falls and hip fracture among clinically defined high-risk elderly individuals: a randomized controlled trialKeizo Sakamoto, Toshitaka Nakamura, Hiroshi Hagino, et al.
Pageof 5